Kirkland Advises ARCHIMED on Final Close of Oversubscribed €1.5 Billion MED IV Fund
Kirkland & Ellis advised ARCHIMED, a global private equity specialist exclusively focused on healthcare, on the successful final close of MED IV fund at its €1.5 billion ($1.75 billion) hard cap. Launched in January 2026 with an original target of €1.2 billion ($1.4 billion), the fund closed in less than six months and was three times oversubscribed, reflecting strong, sustained demand from existing and new investors.
The Kirkland team included investment funds lawyers Raphaël Bloch, Richard Watkins, Christopher Braunack and Sebastien Clisson.
